FDA Inspection 1026371 — Aspen Pharma Trading Ltd.

Aspen Pharma Trading Ltd. — FEI 3012882574

The FDA completed an inspection of Aspen Pharma Trading Ltd. on September 20, 2017 in Dublin 24. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 20, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dublin 24 (Ireland)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report